Santen Pharmaceutical Co., Ltd. (SNPHY)
OTCMKTS
· Delayed Price · Currency is USD
10.71
+0.76 (7.58%)
May 15, 2025, 2:36 PM EDT
Santen Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 15, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 3,473 | 3,185 | 3,697 | 3,192 | 4,043 | 5,505 | Upgrade
|
| Market Cap Growth | -13.85% | -13.85% | 15.82% | -21.04% | -26.56% | -20.18% | Upgrade
|
| Enterprise Value | 2,828 | 2,660 | 3,150 | 2,727 | 3,479 | 5,022 | Upgrade
|
| Last Close Price | 10.71 | 9.47 | 9.75 | 8.46 | 9.98 | 13.88 | Upgrade
|
| PE Ratio | 14.34 | 13.16 | 21.00 | - | 18.04 | 89.19 | Upgrade
|
| PS Ratio | 1.73 | 1.59 | 1.85 | 1.52 | 1.84 | 2.44 | Upgrade
|
| PB Ratio | 1.82 | 1.67 | 1.83 | 1.45 | 1.46 | 1.98 | Upgrade
|
| P/TBV Ratio | 2.47 | 2.26 | 2.52 | 2.15 | 2.37 | 3.13 | Upgrade
|
| P/FCF Ratio | 9.58 | 8.79 | 8.83 | 21.36 | 17.11 | 17.56 | Upgrade
|
| P/OCF Ratio | 8.54 | 7.83 | 7.70 | 11.42 | 10.66 | 15.69 | Upgrade
|
| EV/Sales Ratio | 1.37 | 1.33 | 1.58 | 1.30 | 1.59 | 2.23 | Upgrade
|
| EV/EBITDA Ratio | 6.43 | 6.14 | 6.77 | 6.90 | 7.98 | 7.90 | Upgrade
|
| EV/EBIT Ratio | 8.93 | 8.50 | 9.13 | 10.27 | 11.78 | 10.38 | Upgrade
|
| EV/FCF Ratio | 7.80 | 7.34 | 7.52 | 18.24 | 14.72 | 16.02 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.11 | 0.12 | 0.10 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.49 | 0.69 | 0.62 | 0.14 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.55 | 1.82 | 1.15 | 0.29 | Upgrade
|
| Asset Turnover | 0.71 | 0.71 | 0.71 | 0.63 | 0.62 | 0.62 | Upgrade
|
| Inventory Turnover | 2.72 | 2.72 | 2.99 | 2.95 | 2.79 | 2.56 | Upgrade
|
| Quick Ratio | 1.90 | 1.90 | 2.00 | 1.85 | 1.91 | 2.02 | Upgrade
|
| Current Ratio | 2.58 | 2.58 | 2.55 | 2.38 | 2.39 | 2.63 | Upgrade
|
| Return on Equity (ROE) | 12.14% | 12.14% | 8.92% | -4.75% | 8.45% | 2.18% | Upgrade
|
| Return on Assets (ROA) | 6.93% | 6.93% | 7.61% | 5.01% | 5.20% | 8.25% | Upgrade
|
| Return on Capital (ROIC) | 9.37% | 9.37% | 9.74% | 6.31% | 6.53% | 10.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.50% | 14.50% | 15.20% | 10.60% | 9.90% | 16.50% | Upgrade
|
| Earnings Yield | 6.97% | 7.60% | 4.76% | -3.52% | 5.54% | 1.12% | Upgrade
|
| FCF Yield | 10.43% | 11.38% | 11.33% | 4.68% | 5.85% | 5.70% | Upgrade
|
| Dividend Yield | 2.43% | - | 2.24% | 2.84% | 2.64% | 1.82% | Upgrade
|
| Payout Ratio | 33.40% | 33.40% | 44.59% | - | 44.07% | 163.81% | Upgrade
|
| Buyback Yield / Dilution | 5.01% | 5.01% | 4.98% | 3.26% | -0.02% | -0.03% | Upgrade
|
| Total Shareholder Return | 7.45% | 5.01% | 7.22% | 6.10% | 2.62% | 1.79% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.